[go: up one dir, main page]

AR105492A1 - METHODS FOR THE DIAGNOSIS AND TREATMENT OF INTESTINAL INFLAMMATORY DISEASE - Google Patents

METHODS FOR THE DIAGNOSIS AND TREATMENT OF INTESTINAL INFLAMMATORY DISEASE

Info

Publication number
AR105492A1
AR105492A1 ARP160102273A ARP160102273A AR105492A1 AR 105492 A1 AR105492 A1 AR 105492A1 AR P160102273 A ARP160102273 A AR P160102273A AR P160102273 A ARP160102273 A AR P160102273A AR 105492 A1 AR105492 A1 AR 105492A1
Authority
AR
Argentina
Prior art keywords
methods
treatment
diagnosis
inflammatory disease
biomarkers
Prior art date
Application number
ARP160102273A
Other languages
Spanish (es)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AR105492A1 publication Critical patent/AR105492A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Se proporcionan biomarcadores predictivos de la capacidad de respuesta a los antagonistas de la integrina b7, incluyendo anticuerpos de la subunidad de la integrina anti-b7, y métodos de uso de tales biomarcadores. Además, se proporcionan métodos de tratamiento de trastornos inflamatorios gastrointestinales, tales como enfermedades inflamatorias intestinales incluyendo la colitis ulcerosa y la enfermedad de Crohn. También se proporcionan métodos de uso de tales biomarcadores predictivos para el tratamiento de enfermedades inflamatorias intestinales incluyendo la colitis ulcerosa y la enfermedad de Crohn.Biomarkers predictive of responsiveness to b7 integrin antagonists, including antibodies to the anti-b7 integrin subunit, and methods of use of such biomarkers are provided. In addition, methods of treating gastrointestinal inflammatory disorders, such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease, are provided. Methods of using such predictive biomarkers for the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn's disease are also provided.

ARP160102273A 2015-07-27 2016-07-26 METHODS FOR THE DIAGNOSIS AND TREATMENT OF INTESTINAL INFLAMMATORY DISEASE AR105492A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562197293P 2015-07-27 2015-07-27

Publications (1)

Publication Number Publication Date
AR105492A1 true AR105492A1 (en) 2017-10-11

Family

ID=60244676

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160102273A AR105492A1 (en) 2015-07-27 2016-07-26 METHODS FOR THE DIAGNOSIS AND TREATMENT OF INTESTINAL INFLAMMATORY DISEASE

Country Status (1)

Country Link
AR (1) AR105492A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113226357A (en) * 2018-11-23 2021-08-06 斯特赖克药物公司 Bispecific conjugates

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113226357A (en) * 2018-11-23 2021-08-06 斯特赖克药物公司 Bispecific conjugates

Similar Documents

Publication Publication Date Title
AR092908A1 (en) METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY INTESTINAL DISEASE
MX2022010809A (en) Methods for diagnosing and treating inflammatory bowel disease.
AR103782A1 (en) INTEGRINE b7 ANTAGONISTS AND METHODS OF TREATMENT OF CROHN'S DISEASE
MX2015015784A (en) Methods for diagnosing and treating inflammatory bowel disease.
EP3556773A4 (en) ANTIBODIES TO HUMAN CD73
BR112016021626A2 (en) 5-substituted indazol-3-carboxamides and their preparation and use
HUE053939T2 (en) Deuterated heterocyclic compounds and their use as imaging contrast agents
MX2020001160A (en) ANTIBODIES AND ASSAYS FOR THE DETECTION OF FOLATE RECEPTOR 1.
MX2017014375A (en) Ccr2 modulators.
CO2019006257A2 (en) Probiotics for use in diverticulosis and diverticular disease
LT2890717T (en) DIAGNOSTIC TESTS AND KITS FOR THE DETERMINATION OF FOLATE RECEPTOR 1
IL242789B (en) Determining the Levin orbit (od) using Doppler and elements of Kepler's orbit
BR112017009764A2 (en) bispecific antibodies and methods of use in ophthalmology
IL262728A (en) Oligonucleotides conjugated to the ligand complex of the glp-1 receptor and their uses
MA40871A (en) DIRECT EXPRESSION OF ANTIBODIES
PH12017502099A1 (en) Methods for diagnosing and assessing treatment for cushing's syndrome
CR20170470A (en) TREATMENT OF PATIENTS WITH MELLITUS DIABETES TYPE 2
AR105492A1 (en) METHODS FOR THE DIAGNOSIS AND TREATMENT OF INTESTINAL INFLAMMATORY DISEASE
ES1162833Y (en) Device to exercise the pelvic floor muscles.
TR201905436T4 (en) New ep4 agonists as therapeutic compounds.
WO2017019673A3 (en) Methods for diagnosing and treating inflammatory bowel disease
CL2016000753A1 (en) Attenuation of neurodegeneration associated with parkison's disease by inhibiting the dopamine d3 receptor in t cd4 + cells.
PL3148588T3 (en) N, N-BIS-2-MERCAPTOETHYLISOPHTALAMIDE FOR THE TREATMENT OF PARKINSON'S DISEASE
ES1168633Y (en) Ring to reduce sensitivity in the glans penis
TH1601000717A (en) The use of andrographolide in the preparation of pharmaceuticals for therapy Inflammatory bowel disease, enteric-targeting micropellets of Endrographolides, and methods for their preparation

Legal Events

Date Code Title Description
FB Suspension of granting procedure